tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CVKD Stock Latest News

Cadrenal Therapeutics Acquires eXIthera’s Assets for Growth
Company AnnouncementsCadrenal Therapeutics Acquires eXIthera’s Assets for Growth
5d ago
8K
CVKD
Cadrenal announces acquisition of assets of eXIthera Pharmaceuticals
PremiumThe Fly
Cadrenal announces acquisition of assets of eXIthera Pharmaceuticals
5d ago
CVKD
Cadrenal Therapeutics Advances Tecarfarin Development
PremiumCompany Announcements
Cadrenal Therapeutics Advances Tecarfarin Development
1M ago
CVKD
Cadrenal Therapeutics reports Q2 EPS ($1.87), consensus ($1.77)
PremiumThe Fly
Cadrenal Therapeutics reports Q2 EPS ($1.87), consensus ($1.77)
1M ago
CVKD
Cadrenal Therapeutics to Initiate Tecarfarin Clinical Trial
PremiumCompany Announcements
Cadrenal Therapeutics to Initiate Tecarfarin Clinical Trial
2M ago
8K
CVKD
Cadrenal Therapeutics announces trial plans for tecarfarin
PremiumThe FlyCadrenal Therapeutics announces trial plans for tecarfarin
2M ago
CVKD
Cadrenal Therapeutics Director Resignation Announced
Premium
Company Announcements
Cadrenal Therapeutics Director Resignation Announced
2M ago
8K
CVKD
Positive Outlook for Cadrenal Therapeutics, Inc. Amid Strategic Developments and FDA Trial Milestone
Premium
Ratings
Positive Outlook for Cadrenal Therapeutics, Inc. Amid Strategic Developments and FDA Trial Milestone
4M ago
CVKD
Cadrenal Therapeutics Reports Increased Losses Amid R&D Expansion
PremiumCompany Announcements
Cadrenal Therapeutics Reports Increased Losses Amid R&D Expansion
4M ago
CVKD
Cadrenal Therapeutics Advances Tecarfarin Development in 2024
PremiumCompany Announcements
Cadrenal Therapeutics Advances Tecarfarin Development in 2024
6M ago
CVKD
Cadrenal Therapeutics teams with Abbott inTECH-LVAD trial
PremiumThe Fly
Cadrenal Therapeutics teams with Abbott inTECH-LVAD trial
7M ago
ABT
CVKD
Cadrenal Therapeutics Appoints New Chief Medical Officer
PremiumCompany Announcements
Cadrenal Therapeutics Appoints New Chief Medical Officer
7M ago
8K
CVKD
Cadrenal Therapeutics CMO Douglas Losordo departs, James Ferguson succeeds
PremiumThe FlyCadrenal Therapeutics CMO Douglas Losordo departs, James Ferguson succeeds
8M ago
CVKD
MTNB
Cadrenal Therapeutics to initiate Phase 3 clinical trial for tecarfarin in 2025
Premium
The Fly
Cadrenal Therapeutics to initiate Phase 3 clinical trial for tecarfarin in 2025
9M ago
CVKD
Cadrenal Therapeutics files to sell 590K shares of common stock for holders
Premium
The Fly
Cadrenal Therapeutics files to sell 590K shares of common stock for holders
10M ago
CVKD
Cadrenal Therapeutics target adjusted to $32 from $3 at H.C. Wainwright
PremiumThe Fly
Cadrenal Therapeutics target adjusted to $32 from $3 at H.C. Wainwright
11M ago
CVKD
Cadrenal Therapeutics Advances Tecarfarin Development
PremiumCompany Announcements
Cadrenal Therapeutics Advances Tecarfarin Development
11M ago
CVKD
Cadrenal Therapeutics Raises $5.1 Million for Tecarfarin
PremiumCompany Announcements
Cadrenal Therapeutics Raises $5.1 Million for Tecarfarin
11M ago
8K
CVKD
Cadrenal Therapeutics raises $5.1M via at-the-market facility
PremiumThe Fly
Cadrenal Therapeutics raises $5.1M via at-the-market facility
11M ago
CVKD
Cadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy
PremiumCompany AnnouncementsCadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy
12M ago
8K
CVKD
Cadrenal Therapeutics to discuss tecarfarin trial with FDA in September
Premium
The Fly
Cadrenal Therapeutics to discuss tecarfarin trial with FDA in September
1y ago
CVKD
Cadrenal Therapeutics Inc trading resumes
Premium
The Fly
Cadrenal Therapeutics Inc trading resumes
1y ago
CVKD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >